| Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis PE Lazzerini, PL Capecchi, F Laghi-Pasini European heart journal 38 (22), 1717-1727, 2017 | 345 | 2017 |
| COVID-19, arrhythmic risk, and inflammation: mind the gap! PE Lazzerini, M Boutjdir, PL Capecchi Circulation 142 (1), 7-9, 2020 | 301 | 2020 |
| Worldwide survey of COVID-19–associated arrhythmias EJ Coromilas, S Kochav, I Goldenthal, A Biviano, H Garan, S Goldbarg, ... Circulation: Arrhythmia and Electrophysiology 14 (3), e009458, 2021 | 207 | 2021 |
| Simvastatin inhibits T‐cell activation by selectively impairing the function of Ras superfamily GTPases R Ghittoni, L Patrussi, K Pirozzi, M Pellegrini, PE Lazzerini, PL Capecchi, ... The FASEB journal 19 (6), 1-24, 2005 | 185 | 2005 |
| Cardioimmunology of arrhythmias: the role of autoimmune and inflammatory cardiac channelopathies PE Lazzerini, F Laghi-Pasini, M Boutjdir, PL Capecchi Nature Reviews Immunology 19 (1), 63-64, 2019 | 176 | 2019 |
| Hyperhomocysteinemia, inflammation and autoimmunity PE Lazzerini, PL Capecchi, E Selvi, S Lorenzini, S Bisogno, M Galeazzi, ... Autoimmunity reviews 6 (7), 503-509, 2007 | 170 | 2007 |
| Long QT syndrome: an emerging role for inflammation and immunity PE Lazzerini, PL Capecchi, F Laghi-Pasini Frontiers in cardiovascular medicine 2, 26, 2015 | 159 | 2015 |
| Systemic inflammation rapidly induces reversible atrial electrical remodeling: the role of interleukin‐6–mediated changes in connexin expression PE Lazzerini, F Laghi‐Pasini, M Acampa, U Srivastava, I Bertolozzi, ... Journal of the American Heart Association 8 (16), e011006, 2019 | 148 | 2019 |
| Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation AS Aromolaran, U Srivastava, A Alí, M Chahine, D Lazaro, N El-Sherif, ... PLoS One 13 (12), e0208321, 2018 | 136 | 2018 |
| Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes PE Lazzerini, F Laghi-Pasini, I Bertolozzi, G Morozzi, S Lorenzini, ... Heart 103 (22), 1821-1829, 2017 | 119 | 2017 |
| Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias PE Lazzerini, PL Capecchi, F Laghi-Pasini, M Boutjdir Nature Reviews Cardiology 14 (9), 521-535, 2017 | 114 | 2017 |
| Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation K Varani, F Laghi‐Pasini, A Camurri, PL Capecchi, M Maccherini, ... The FASEB Journal 17 (2), 280-282, 2003 | 113 | 2003 |
| Prolongation of the corrected QT interval in adult patients with anti‐Ro/SSA–positive connective tissue diseases PE Lazzerini, M Acampa, F Guideri, PL Capecchi, V Campanella, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2004 | 112 | 2004 |
| Emerging arrhythmic risk of autoimmune and inflammatory cardiac channelopathies PE Lazzerini, PL Capecchi, N El‐Sherif, F Laghi‐Pasini, M Boutjdir Journal of the American Heart Association 7 (22), e010595, 2018 | 111 | 2018 |
| Antiarrhythmic potential of anticytokine therapy in rheumatoid arthritis: tocilizumab reduces corrected QT interval by controlling systemic inflammation PE Lazzerini, M Acampa, PL Capecchi, I Fineschi, E Selvi, V Moscadelli, ... Arthritis care & research 67 (3), 332-339, 2015 | 108 | 2015 |
| Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation PE Lazzerini, PL Capecchi, M Acampa, M Galeazzi, F Laghi-Pasini Autoimmunity reviews 13 (9), 936-944, 2014 | 106 | 2014 |
| Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis EG Gonzalez, E Selvi, E Balistreri, A Akhmetshina, K Palumbo, ... Annals of the rheumatic diseases 71 (9), 1545-1551, 2012 | 94 | 2012 |
| Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease PE Lazzerini, PL Capecchi, F Guideri, F Bellisai, E Selvi, M Acampa, ... The American journal of cardiology 100 (6), 1029-1034, 2007 | 93 | 2007 |
| Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis PE Lazzerini, M Acampa, PL Capecchi, M Hammoud, S Maffei, S Bisogno, ... European journal of internal medicine 24 (4), 368-374, 2013 | 90 | 2013 |
| Simvastatin inhibits cytokine production and nuclear factor-kB activation in interleukin 1 beta-stimulated synoviocytes from rheumatoid arthritis patients PE Lazzerini, S Lorenzini, E Selvi, PL Capecchi, D Chindamo, S Bisogno, ... Clinical and experimental rheumatology 25 (5), 696, 2007 | 88 | 2007 |
